MatsukiyoCocokara & Co.
MatsukiyoCocokara & Co. Second Quarter (Interim) Financial Summary
For the second quarter of the fiscal year ending March 2027, consolidated net sales were 577,518 hundred million yen, a 5.2% year-over-year increase. Operating income was 41,762 hundred million yen, and net income attributable to owners of parent for the interim period was 28,576 hundred million yen (a 7.8% year-over-year increase). Full-year forecasts for 2027 were left unchanged. The most recent dividend forecast remains 58 yen for the full year (no interim or third-quarter dividends, includes year-end forecast).
Key Figures
- Net Sales: 577,518 hundred million yen (Year-over-Year 5.2% increase)
- Operating Income: 41,762 hundred million yen (Year-over-Year 3.3% increase)
- Net Income Attributable to Owners of Parent (interim): 28,576 hundred million yen (Year-over-Year 7.8% increase)
AI要約
Overview of Results
Consolidated net sales for the interim period were 577,518 hundred million yen, representing a 5.2% increase versus the same period last year. By segment, the Matsumoto Kiyoshi Group business recorded sales growth, while the Cocokara Fine Group saw a slight decline. Overall, the Group maintained steady growth. Operating income was 41,762 hundred million yen, ordinary income was 44,580 hundred million yen, and interim net income was 28,576 hundred million yen, all exceeding the prior year.
Business Strategy and Outlook
The Company continues initiatives to achieve the Group management targets for the fiscal year ending March 2031, including strengthening the platform centered on differentiation strategies, improving convenience through digital investments, expanding the store network and promoting stores with dispensing functions, and accelerating overseas expansion. Organizational strengthening associated with newly consolidated subsidiaries such as Universal Drug and Johnmaster HD is also underway.
MatsukiyoCocokara & Co.
Company overview · Stock price · Financial data · All IR
